The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future
Elif Hindié
Eur J Nucl Med Mol Imaging. 2024-05-13; :
DOI: 10.1007/s00259-024-06758-y
![PubMed](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2019/01/logoPubMed.png)
Read on PubMed
Eur J Nucl Med Mol Imaging. 2024-05-13; :
DOI: 10.1007/s00259-024-06758-y
![PubMed](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2019/01/logoPubMed.png)
Read on PubMed
Hindié E(1)(2)(3).
Author information:
(1)Service de Médecine Nucléaire, CHU de Bordeaux, Université de Bordeaux,
Talence, F-33400, France. .
(2)Institut Universitaire de France, 1 rue Descartes, Paris cedex 05, 75231,
France. .
(3)Nuclear Medicine Department, University Hospitals of Bordeaux, Pessac, 33604,
France. .
DOI: 10.1007/s00259-024-06758-y
PMID: 38735885